Trauma segment experiences slight sequential gains as product intros gain traction and companies overcome supply disruption.
The WW Trauma Market ended Q2 posting +1.5% (reported) growth, with the US Market driving growth up 3.6% YOY, slightly up sequentially compared to Q1’s 3.2% gains. Internationally, Europe and ROW fared worse due to missed tenders, with -2.1% and -1.1% growth, respectively. Looking forward, SmartTRAK anticipates the trauma segment will see...
- Q219 Trauma Market Financial Highlights
- Q219 US Upswing Possibly Indicative of a Stronger Second Half of the Year
- Small Players Gain Momentum
- Trauma Regulatory Highlights
SmartTRAK continues to believe that a lull in innovation from market leaders opens the door for disruption from new players in the trauma market - such as Globus and NuVasive ...
*The entire article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.